Payment overview · 2025
General Payments
$23.82
1 reported records · 1 companies
Healthcare provider profile · identity verified
Danielle N. Harris, NP-C
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · BRANDON, FL · NPI 1932507720
Verified facts
What the public records show
CMS Open Payments records show Danielle N. Harris, NP-C received $23.82 in general payments during 2025 across 1 reported records.
SCPHARMACEUTICALS INC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| SCPHARMACEUTICALS INC. | Unresolved — no canonical attribution shown | $23.82 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $23.82 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FUROSCIX Normalized: furoscix |
Drug | SCPHARMACEUTICALS INC. | $23.82 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 735 | 286 |
| Amlodipine Besylate | Amlodipine Besylate | 506 | 199 |
| Levothyroxine Sodium | Levothyroxine Sodium | 499 | 182 |
| Gabapentin | Gabapentin | 409 | 141 |
| Lisinopril | Lisinopril | 363 | 130 |
| Losartan Potassium | Losartan Potassium | 359 | 145 |
| Omeprazole | Omeprazole | 349 | 109 |
| Pantoprazole Sodium | Pantoprazole Sodium | 339 | 118 |
| Metformin Hcl | Metformin Hcl | 329 | 128 |
| Metoprolol Succinate | Metoprolol Succinate | 312 | 105 |
| Simvastatin | Simvastatin | 309 | 106 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 306 | 124 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 209 | 74 |
| Montelukast Sodium | Montelukast Sodium | 207 | 68 |
| Metoprolol Tartrate | Metoprolol Tartrate | 204 | 76 |
| Hydrochlorothiazide | Hydrochlorothiazide | 203 | 79 |
| Tamsulosin Hcl | Tamsulosin Hcl | 197 | 68 |
| Sertraline Hcl | Sertraline Hcl | 196 | 65 |
| Carvedilol | Carvedilol | 183 | 62 |
| Escitalopram Oxalate | Escitalopram Oxalate | 171 | 56 |
| Furosemide | Furosemide | 167 | 65 |
| Clopidogrel | Clopidogrel Bisulfate | 160 | 58 |
| Meloxicam | Meloxicam | 159 | 42 |
| Ezetimibe | Ezetimibe | 154 | 51 |
| Fluticasone Propionate | Fluticasone Propionate | 154 | 55 |
| Eliquis | Apixaban | 151 | 52 |
| Famotidine | Famotidine | 140 | 56 |
| Trazodone Hcl | Trazodone Hcl | 137 | 54 |
| Metformin Hcl Er | Metformin Hcl | 131 | 49 |
| Duloxetine Hcl | Duloxetine Hcl | 120 | 47 |
| Allopurinol | Allopurinol | 115 | 41 |
| Baclofen | Baclofen | 112 | 33 |
| Ozempic | Semaglutide | 107 | 27 |
| Glimepiride | Glimepiride | 97 | 43 |
| Pravastatin Sodium | Pravastatin Sodium | 97 | 41 |
| Alendronate Sodium | Alendronate Sodium | 96 | 39 |
| Tizanidine Hcl | Tizanidine Hcl | 94 | 37 |
| Potassium Chloride | Potassium Chloride | 87 | 35 |
| Jardiance | Empagliflozin | 84 | 34 |
| Meclizine Hcl | Meclizine Hcl | 82 | 25 |
| Synthroid | Levothyroxine Sodium | 82 | 25 |
| Finasteride | Finasteride | 81 | 26 |
| Memantine Hcl | Memantine Hcl | 80 | 23 |
| Atenolol | Atenolol | 79 | 27 |
| Prednisone | Prednisone | 72 | 58 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 70 | 21 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 69 | 24 |
| Glipizide Er | Glipizide | 67 | 24 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 66 | 28 |
| Mounjaro | Tirzepatide | 65 | 16 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 64 | 55 |
| Donepezil Hcl | Donepezil Hcl | 64 | 28 |
| Ibuprofen | Ibuprofen | 58 | 27 |
| Buspirone Hcl | Buspirone Hcl | 56 | 16 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 55 | 25 |
| Glipizide | Glipizide | 53 | 20 |
| Fluoxetine Hcl | Fluoxetine Hcl | 51 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 48 | 23 |
| Bupropion Xl | Bupropion Hcl | 47 | 13 |
| Nifedipine Er | Nifedipine | 47 | 24 |
| Topiramate | Topiramate | 46 | 14 |
| Warfarin Sodium | Warfarin Sodium | 44 | 14 |
| Azithromycin | Azithromycin | 43 | 42 |
| Benazepril Hcl | Benazepril Hcl | 43 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 43 | 16 |
| Farxiga | Dapagliflozin Propanediol | 41 | 14 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 41 | 16 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 41 | 16 |
| Celecoxib | Celecoxib | 40 | 16 |
| Quetiapine Fumarate | Quetiapine Fumarate | 40 | 16 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 39 | 12 |
| Nystatin | Nystatin | 38 | 14 |
| Paroxetine Hcl | Paroxetine Hcl | 38 | 12 |
| Rizatriptan | Rizatriptan Benzoate | 38 | suppressed |
| Spironolactone | Spironolactone | 38 | 19 |
| Nitroglycerin | Nitroglycerin | 37 | 17 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 37 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 37 | 14 |
| Bumetanide | Bumetanide | 36 | 12 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 35 | 11 |
| Valacyclovir | Valacyclovir Hcl | 35 | 16 |
| Ondansetron Odt | Ondansetron | 34 | 17 |
| Diclofenac Sodium | Diclofenac Sodium | 33 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 33 | 28 |
| Mirtazapine | Mirtazapine | 32 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 31 | suppressed |
| Fenofibrate | Fenofibrate | 31 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 31 | 16 |
| Sucralfate | Sucralfate | 31 | 12 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 31 | 15 |
| Myrbetriq | Mirabegron | 30 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 30 | 13 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 30 | suppressed |
| Primidone | Primidone | 30 | suppressed |
| Valsartan | Valsartan | 30 | 15 |
| Estradiol | Estradiol | 29 | suppressed |
| Fluconazole | Fluconazole | 29 | 23 |
| Tresiba Flextouch U-100 | Insulin Degludec | 29 | 14 |
| Trulicity | Dulaglutide | 29 | suppressed |
| Lovastatin | Lovastatin | 27 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 26 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 26 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 26 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 26 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 26 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 25 | 13 |
| Sildenafil Citrate | Sildenafil Citrate | 25 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 24 | 13 |
| Doxycycline Hyclate | Doxycycline Hyclate | 23 | 22 |
| Enalapril Maleate | Enalapril Maleate | 23 | 12 |
| Clonidine Hcl | Clonidine Hcl | 22 | 11 |
| Mometasone Furoate | Mometasone Furoate | 22 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 22 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 22 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 21 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 21 | suppressed |
| Hydrocortisone | Hydrocortisone | 21 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 21 | suppressed |
| Januvia | Sitagliptin Phosphate | 21 | suppressed |
| Tadalafil | Tadalafil | 21 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 21 | suppressed |
| Xarelto | Rivaroxaban | 21 | 11 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 20 | suppressed |
| Lidocaine | Lidocaine | 20 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 20 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 20 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 20 | 11 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 19 | suppressed |
| Levetiracetam | Levetiracetam | 19 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 18 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 18 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 17 | suppressed |
| Irbesartan | Irbesartan | 17 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 16 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 15 | suppressed |
| Rybelsus | Semaglutide | 15 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 15 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 14 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 14 | suppressed |
| Entresto | Sacubitril/Valsartan | 14 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 14 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Naproxen | Naproxen | 14 | suppressed |
| Novolog Flexpen | Insulin Aspart | 14 | suppressed |
| Prolia | Denosumab | 14 | 13 |
| Propranolol Hcl | Propranolol Hcl | 14 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 14 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 13 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 13 | suppressed |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 13 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Repatha Syringe | Evolocumab | 13 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 13 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Cilostazol | Cilostazol | 12 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Methotrexate | Methotrexate Sodium | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | 12 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 12 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 12 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 11 | suppressed |
| Lactulose | Lactulose | 11 | suppressed |
| Lansoprazole | Lansoprazole | 11 | suppressed |
| Methocarbamol | Methocarbamol | 11 | suppressed |
| Novolog | Insulin Aspart | 11 | suppressed |
| Repatha Sureclick | Evolocumab | 11 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $23.82 · 1 records | SCPHARMACEUTICALS INC. | FUROSCIX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error